Company intelligence / Profile preview

DI Biotech

Seoul, Seoul-teukbyeolsi (Seoul Special City), South Koreazoominfo.com ↗

Ownership: Private
Development stage: Other

Overview

DI Biotech is a South Korea-based biotechnology company specializing in the distribution, marketing, and support of advanced laboratory instruments and bioanalytical systems for life science research, including immunoassay platforms such as Gyrolab[1][2]. The company does not appear to have its own clinical pipeline but plays an important role in supporting biopharma R&D through technology provision.

Modalities: DeviceProtein
Industry: Drug Discovery Services

Partnerships

Gyros AB (distribution/license agreement for Gyrolab immunoassay system)

Beyond the preview

Go deeper on DI Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DI Biotech.

Explore the full profile